CLASS II Drug recall · Reported 15 Jan 2020 · FDA Enforcement Report

Estriol, USP, (Micronized) recalled by Asclemed USA

Asclemed USA is recalling Estriol, USP, (Micronized), distributed in California. The recall was initiated on 9 Dec 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code/Exp. Date: 11191804, 12281802, 01211902, 01281901, 02071903, 02221902, 03111903, 03251902, 04011905, 04091903, 04221907, 05211902, 06071902, 06241903, 07111903, 07301902, 08271902, 09061904, 09161902, EXP 12/31/2020; 09161901, 10091905, 10221902, 10311901, EXP 5/31/2021; 11211902, 10311902, EXP 8/31/2021
Quantity recalled56.4 gm

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0652-2020
FDA event ID
84550
Recalling firm
Asclemed USA, Torrance, CA
Classification
Class II
Status
Terminated
Recall initiated
9 Dec 2019
FDA classified
8 Jan 2020
Reported
15 Jan 2020
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Potency & Assay

Timeline

9 Dec 2019Recall initiated by company
8 Jan 2020Classified by FDA+30 days
15 Jan 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Estriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-38

Where it was distributed

Product was distributed to 6 physician's offices within the state of California.

California

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.

Which lots are affected?

Lot Code/Exp. Date: 11191804, 12281802, 01211902, 01281901, 02071903, 02221902, 03111903, 03251902, 04011905, 04091903, 04221907, 05211902, 06071902, 06241903, 07111903, 07301902, 08271902, 09061904, 09161902, EXP 12/31/2020; 09161901, 10091905, 10221902, 10311901, EXP 5/31/2021; 11211902, 10311902, EXP 8/31/2021

Where was it sold?

Product was distributed to 6 physician's offices within the state of California.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 84550

This product is part of a recall event; the main page for the event is Estriol, USP, (Micronized) recalled by Asclemed USA.

More recalls from Asclemed USA

All 10
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIILidolog Kit, Kit Contains: Lidocaine HCl Injection recalledLidolog KitAsclemed USAOtherTN
DrugCLASS IILidocaine HCl Injection USP, 1% (10 mg/mL) single dose ampule recalledLidocaine HydrochlorideAsclemed USASterilityNationwide
DrugCLASS IIAccucaine, Kit contains: Lidocaine HCl Injection recalledAccucaineAsclemed USASterilityNationwide
DrugCLASS IIDuloxetine DR Capsules, 30 mg, Rx, Relabeled recalled by Asclemed USADuloxetineAsclemed USANitrosamine ImpurityNationwide
DrugCLASS IIIAsclemed USA products recalledAsclemed USAOtherAL, CA, LA

Other Estriol recalls

All 13